Skip to main content

Transcode Therapeutics, Inc. (RNAZ)

Sector
Healthcare
Industry
Biotechnology
Last price
$1.41
As of

Kresmion compiles this page from RNAZ's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Transcode Therapeutics, Inc. (RNAZ): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-16.

As of . Source: SEC EDGAR filings for RNAZ. Method and limitations.

COMPANY DOSSIER

See the full RNAZ dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for RNAZ on one page. Preview it with sample data, then open it live with a free account.

Preview the RNAZ dossier

Active events for RNAZ

  • mediumEarnings above estimates

    Q1-2024: Beat consensus by 24.4% - EPS $-498.96 vs $-659.736 estimate

FREE, NO ACCOUNT

Every event on RNAZ, as it fires

New filings, 13F moves and cross asset events on RNAZ land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, RNAZ

Going concern statement

RNAZ's 10-Q filed Nov 16, 2026 states:

…Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming…

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on RNAZ

RNAZ mentioned in Kresmion daily briefs

Cite this data

Kresmion counts the managers it follows that reported a non-option position in RNAZ on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on RNAZ in the last 180 days.

Upstream: SEC EDGAR filings for RNAZ

Kresmion, "Transcode Therapeutics, Inc. (RNAZ) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/RNAZ. Upstream data: SEC EDGAR filings for RNAZ.

Link to this data (HTML):

<a href="https://kresmion.com/research/RNAZ">Transcode Therapeutics, Inc. (RNAZ) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow RNAZ on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to RNAZ for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the RNAZ dossier
Share

The RNAZ intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.